MARK2 and cancer: The mechanistic/mammalian target of rapamycin (mTOR) is a Serine/Threonine kinase, that plays a central role in regulating human physiological activities including tissue regeneration, regulatory T cell differentiation, and function, and various types of cancers (Sabatini, 2017).